Voloridge Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,230
Closed -$769K 1646
2023
Q2
$769K Buy
+15,230
New +$810K ﹤0.01% 1164
2022
Q1
Sell
-17,561
Closed -$983K 1769
2021
Q4
$983K Sell
17,561
-242
-1% -$14.8K 0.01% 1265
2021
Q3
$1.16M Buy
+17,803
New +$1.22M 0.01% 1238
2021
Q2
Sell
-11,026
Closed -$660K 1831
2021
Q1
$660K Buy
+11,026
New +$600K ﹤0.01% 1132
2020
Q4
Sell
-20,135
Closed -$1.03M 1626
2020
Q3
$1.03M Buy
+20,135
New +$841K 0.01% 931
2019
Q4
Sell
-11,275
Closed -$304K 1402
2019
Q3
$304K Buy
+11,275
New +$393K 0.01% 927

Other funds holding AXNX

Voloridge Investment Management's AXNX Position: Q3 2023 in Review

Voloridge Investment Management sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 15,230 shares — an estimated $769K sold.

Voloridge Investment Management first reported a position in AXNX in Q3 2019 and held it in 6 quarters. The position peaked at $1.16M in Q3 2021. 221 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

  • Voloridge Investment Management reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 15,230 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $769K.
  • Voloridge Investment Management first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
  • Voloridge Investment Management's Axonics, Inc. Common Stock position peaked at $1.16M in Q3 2021.
  • 221 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Voloridge Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.